Dr. Wu Skincare Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	326.33	317.5	474.88	651.55	1,029
Short-Term Investments	509.69	591.22	658.47	696.8	366.3
Trading Asset Securities	-	-	18.66	17.77	19.65
Cash & Short-Term Investments	836.03	908.72	1,152	1,366	1,415
Cash Growth	-8.00%	-21.12%	-15.67%	-3.43%	-11.82%
Accounts Receivable	126.04	175.16	138.92	130.52	149.05
Other Receivables	9.33	2.61	2.8	1.84	2.06
Receivables	135.36	177.77	141.71	132.36	151.11
Inventory	168.54	161.79	188.76	115.2	115.18
Prepaid Expenses	24.31	12.21	16.43	3.84	7.84
Other Current Assets	2.89	8.26	125.78	2.04	2.13
Total Current Assets	1,167	1,269	1,625	1,620	1,691
Property, Plant & Equipment	30.62	29.51	7.65	14.54	22.51
Long-Term Investments	360.37	418.6	119.7	134.74	93.33
Other Intangible Assets	0.41	0.6	0.79	0.05	0.25
Long-Term Accounts Receivable	-	17.1	-	1.99	6.68
Long-Term Deferred Tax Assets	7.45	10.41	7.77	6.71	10.07
Other Long-Term Assets	24.75	4.81	4.83	5.63	7.33
Total Assets	1,591	1,750	1,765	1,783	1,831
Accounts Payable	29.8	25.9	62.69	46.71	89.95
Accrued Expenses	-	81	96.88	80.1	95.23
Current Portion of Leases	10.94	9.81	5.05	10.08	9.83
Current Income Taxes Payable	30.26	56.41	80.35	40.51	40.15
Current Unearned Revenue	21.6	11.52	8.26	8.05	13.59
Other Current Liabilities	111.96	68.57	35.65	33.75	30.42
Total Current Liabilities	204.56	253.2	288.88	219.18	279.16
Long-Term Leases	30.04	36.96	-	5.6	15.68
Long-Term Deferred Tax Liabilities	-	3.3	0.98	28.18	-
Other Long-Term Liabilities	1.26	1.26	1.26	1.26	1.26
Total Liabilities	235.86	294.71	291.12	254.22	296.1
Common Stock	450.48	450.48	450.48	450.48	450.48
Additional Paid-In Capital	151.7	241.8	331.89	421.99	512.08
Retained Earnings	752.67	762.78	691.96	548.78	479.09
Comprehensive Income & Other	-	-	-	107.77	93.31
Shareholders' Equity	1,355	1,455	1,474	1,529	1,535
Total Liabilities & Equity	1,591	1,750	1,765	1,783	1,831
Total Debt	40.98	46.77	5.05	15.68	25.5
Net Cash (Debt)	795.05	861.95	1,147	1,350	1,389
Net Cash Growth	-7.76%	-24.85%	-15.07%	-2.78%	-11.54%
Net Cash Per Share	17.59	19.08	25.44	29.95	30.80
Filing Date Shares Outstanding	44.94	45.05	45.05	45.05	45.05
Total Common Shares Outstanding	44.94	45.05	45.05	45.05	45.05
Working Capital	962.56	1,016	1,336	1,400	1,412
Book Value Per Share	30.14	32.30	32.73	33.94	34.07
Tangible Book Value	1,354	1,454	1,474	1,529	1,535
Tangible Book Value Per Share	30.14	32.29	32.71	33.94	34.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.